Hasegawa Hirotaka, Van Gompel Jamie J, Marsh W Richard, Wharen Robert E, Zimmerman Richard S, Burkholder David B, Lundstrom Brian N, Britton Jeffrey W, Meyer Fredric B
Departments of1Neurologic Surgery and.
2Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan.
J Neurosurg. 2020 Dec 18;135(3):783-791. doi: 10.3171/2020.7.JNS201385. Print 2021 Sep 1.
Surgical site infection (SSI) is a rare but significant complication after vagus nerve stimulator (VNS) placement. Treatment options range from antibiotic therapy alone to hardware removal. The optimal therapeutic strategy remains open to debate. Therefore, the authors conducted this retrospective multicenter analysis to provide insight into the optimal management of VNS-related SSI (VNS-SSI).
Under institutional review board approval and utilizing an institutional database with 641 patients who had undergone 808 VNS-related placement surgeries and 31 patients who had undergone VNS-related hardware removal surgeries, the authors retrospectively analyzed VNS-SSI.
Sixteen cases of VNS-SSI were identified; 12 of them had undergone the original VNS placement procedure at the authors' institutions. Thus, the incidence of VNS-SSI was calculated as 1.5%. The mean (± standard deviation) time from the most recent VNS-related surgeries to infection was 42 (± 27) days. Methicillin-sensitive staphylococcus was the usual causative bacteria (58%). Initial treatments included antibiotics with or without nonsurgical procedures (n = 6), nonremoval open surgeries for irrigation (n = 3), generator removal (n = 3), and total or near-total removal of hardware (n = 4). Although 2 patients were successfully treated with antibiotics alone or combined with generator removal, removal of both the generator and leads was eventually required in 14 patients. Mild swallowing difficulties and hoarseness occurred in 2 patients with eventual resolution.
Removal of the VNS including electrode leads combined with antibiotic administration is the definitive treatment but has a risk of causing dysphagia. If the surgeon finds dense scarring around the vagus nerve, the prudent approach is to snip the electrode close to the nerve as opposed to attempting to unwind the lead completely.
手术部位感染(SSI)是迷走神经刺激器(VNS)植入术后一种罕见但严重的并发症。治疗方案从单纯抗生素治疗到取出硬件不等。最佳治疗策略仍存在争议。因此,作者进行了这项回顾性多中心分析,以深入了解VNS相关手术部位感染(VNS-SSI)的最佳管理方法。
在机构审查委员会批准下,作者利用一个机构数据库,该数据库包含641例接受了808次VNS相关植入手术的患者以及31例接受了VNS相关硬件取出手术的患者,对VNS-SSI进行了回顾性分析。
共确定了16例VNS-SSI;其中12例在作者所在机构接受了最初的VNS植入手术。因此,VNS-SSI的发生率计算为1.5%。从最近一次VNS相关手术到感染的平均(±标准差)时间为42(±27)天。甲氧西林敏感葡萄球菌是常见的致病菌(58%)。初始治疗包括使用或不使用非手术程序的抗生素治疗(n = 6)、不取出硬件的开放手术冲洗(n = 3)、发生器取出(n = 3)以及全部或几乎全部取出硬件(n = 4)。虽然2例患者仅通过抗生素单独治疗或联合发生器取出成功治愈,但最终14例患者需要取出发生器和导线。2例患者出现轻度吞咽困难和声音嘶哑,最终症状缓解。
取出包括电极导线在内的VNS并联合使用抗生素是确定性治疗方法,但有导致吞咽困难的风险。如果外科医生发现迷走神经周围有致密瘢痕,谨慎的做法是在靠近神经处剪断电极,而不是试图完全解开导线。